冠状动脉旁路移植的最佳双重抗血小板疗法:系统性审查和元分析
Ali Salman1, Saad Ahmed Waqas1, Jazza Aamir1
1Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan.
概括
在冠状动脉旁路移植 (CABG) 患者中,使用阿司匹林和蒂卡格勒勒的双重抗血小板疗法 (DAPT) 改善了生存率并减少了出血. 在CABG患者中使用prasugrel会增加出血风险,因此需要谨慎使用.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 双抗血小板治疗 (DAPT) 对接受冠状动脉旁路移植 (CABG) 的患者至关重要.
- 为了优化患者的治疗结果,比较不同DAPT疗法的疗效和安全性至关重要.
研究的目的:
- 为了评估DAPT使用阿司匹林与蒂卡格洛尔,克洛皮多格雷尔或普拉苏格雷尔在CABG患者中的疗效和安全性.
- 确定最佳的DAPT策略,以提高生存率并最大限度地减少出血并发症.
主要方法:
- 进行了对19项涉及9585名患者的研究的元分析.
- 包括的研究比较了CABG手术背景下的DAPT疗法.
主要成果:
- 提卡格勒勒在手术前适当停止时,显著降低了全因死亡率和重大出血.
- 普拉苏格勒与增加对血小板输血的需求有关.
- 对于心肌梗塞,中风或红细胞输血,没有发现显著差异.
结论:
- DAPT与阿司匹林和提卡格勒罗尔一起,在CABG患者中提供了最佳的疗效和安全平衡.
- 由于增加出血风险,应谨慎对待CABG患者的prasugrel使用.
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
652
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
652
Coronary Artery Disease V: Interprofessional Care
38
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
38
Peripheral Artery Disease III: Interprofessional Care
32
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
32
Angina IV: Management
28
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
28
Acute Coronary Syndrome IV: Interprofessional Care
32
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
32
Atherosclerosis III: Management
41
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
41


